Filing Details
- Accession Number:
- 0001209191-20-030562
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 17:01:18
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 17:01:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298709 | S Krish Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 3,842 | $57.43 | 1,932,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 12,445 | $58.09 | 1,920,175 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 10,552 | $59.03 | 1,909,623 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-18 | 2,900 | $55.99 | 1,906,723 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-18 | 6,784 | $56.84 | 1,899,939 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-18 | 5,371 | $57.63 | 1,894,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-18 | 1,805 | $59.11 | 1,892,763 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-18 | 6,301 | $59.73 | 1,886,462 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 112,162 | Indirect | By Trust |
| Common Stock | 1,936,064 | Indirect | By Spouse |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.
- This transaction was executed in multiple trades ranging from $56.65 to $57.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $57.65 to $58.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $58.69 to $59.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $55.36 to $56.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $56.37 to $57.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $57.37 to $58.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $58.40 to $59.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $59.42 to $60.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
- Directly beneficially owned by Suma S. Krishnan, the spouse of the reporting person.
Billionaire Hedge Funds
